Abstract: The invention concerns a pulverulent, free-flowing monoglyceride based additive for use in the preparation of farinaceous and starch-containing products such as bread, macaroni, spaghetti, noodles and extruded snack products; this additive has been obtained by spray-cooling a substantially dry mixture containing the monoglyceride in molten condition together with at least one phosphatide, preferably lecithin and especially preferred soybean lecithin so that the individual particles will contain the monoglyceride and the phosphatide in substantially constant proportion. The product gives almost as good baking performance or performance in other heating processes for the dough into which it is incorporated as does a so-called monoglyceride-hydrate and has the further advantage of improving the flowing and packing properties of the pulverulent mixture.
Abstract: As new compounds having .beta.-receptor blocking activity, isopropylamino-(pyridyloxy)-propanols with the general formula ##STR1## wherein R denotes hydrogen or amino. The compounds are prepared by reacting a corresponding 3-pyridinol with epichlorohydrin and the resulting product with isopropylamine.
Abstract: This invention relates to therapeutically active 2,5-tetrahydrofurane derivatives, wherein the substituent in the 2-position is a group ROOC--(CH.sub.2).sub.7, in which R is hydrogen or lower alkyl, the 5-substituent being an alkyl or alkenyl group of 8 to 12 carbon atoms, which may be substituted with an oxygen atom, a hydroxy group or a lower alkyl group at the third carbon atom, counted from the furane ring, and to the production thereof.
Abstract: The invention relates to new 1,4-benzodiazepine derivatives of the formula ##SPC1##Wherein R.sup.1 is hydrogen, halogen, or the trifluoromethyl group, R.sup.2 and R.sup.3 are alkyl groups, and n is an integer from 1 to 4, and acid addition salts thereof, the compounds and salts being soluble in water, and having analgetic, sedative, and narcosis potentiating properties.
Abstract: This invention relates to therapeutically active 2,5-furane derivatives, wherein the substituent in the 2-position is a lower alkyl group or a group ROOC--(CH.sub.2).sub.7 --, in which R is hydrogen or lower alkyl, the 5-substituent being an alkyl or alkylene group of 4 to 13 carbon atoms, which may be substituted with an oxygen atom, a hydroxy group or a lower alkyl group at the third carbon atom, counted from the furane ring, and to the production thereof.